These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 9223629
1. The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins. Van Rampelbergh J, Poloczek P, Françoys I, Delporte C, Winand J, Robberecht P, Waelbroeck M. Biochim Biophys Acta; 1997 Jun 27; 1357(2):249-55. PubMed ID: 9223629 [Abstract] [Full Text] [Related]
2. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states. Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M. Mol Pharmacol; 1996 Dec 27; 50(6):1596-604. PubMed ID: 8967982 [Abstract] [Full Text] [Related]
3. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor. Delporte C, Poloczek P, de Neef P, Vertongen P, Ciccarelli E, Svoboda M, Herchuelz A, Winand J, Robberecht P. Mol Cell Endocrinol; 1995 Jan 27; 107(1):71-6. PubMed ID: 7796937 [Abstract] [Full Text] [Related]
4. PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta. Hezareh M, Schlegel W, Rawlings SR. J Neuroendocrinol; 1996 May 27; 8(5):367-74. PubMed ID: 8736436 [Abstract] [Full Text] [Related]
5. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland. Simonneaux V, Kienlen-Campard P, Loeffler JP, Basille M, Gonzalez BJ, Vaudry H, Robberecht P, Pévet P. Neuroscience; 1998 Aug 27; 85(3):887-96. PubMed ID: 9639281 [Abstract] [Full Text] [Related]
6. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs. Dickinson T, Fleetwood-Walker SM, Mitchell R, Lutz EM. Neuropeptides; 1997 Apr 27; 31(2):175-85. PubMed ID: 9179871 [Abstract] [Full Text] [Related]
11. Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors. Gourlet P, Rathé J, De Neef P, Cnudde J, Vandermeers-Piret MC, Waelbroeck M, Robberecht P. Eur J Pharmacol; 1998 Jul 31; 354(1):105-11. PubMed ID: 9726637 [Abstract] [Full Text] [Related]
12. The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass. Gourlet P, Vertongen P, Vandermeers A, Vandermeers-Piret MC, Rathe J, De Neef P, Waelbroeck M, Robberecht P. Peptides; 1997 Jul 31; 18(3):403-8. PubMed ID: 9145428 [Abstract] [Full Text] [Related]
13. Phospholipase C activation by VIP1 and VIP2 receptors expressed in COS 7 cells involves a pertussis toxin-sensitive mechanism. MacKenzie CJ, Lutz EM, McCulloch DA, Mitchell R, Harmar AJ. Ann N Y Acad Sci; 1996 Dec 26; 805():579-84. PubMed ID: 8993443 [No Abstract] [Full Text] [Related]
14. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages. Pozo D, Delgado M, Martinez C, Gomariz RP, Guerrero JM, Calvo JR. Biochim Biophys Acta; 1997 Dec 12; 1359(3):250-62. PubMed ID: 9434131 [Abstract] [Full Text] [Related]
15. Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells. Murthy KS, Jin JG, Grider JR, Makhlouf GM. Am J Physiol; 1997 Jun 12; 272(6 Pt 1):G1391-9. PubMed ID: 9227474 [Abstract] [Full Text] [Related]
16. Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor. MacKenzie CJ, Lutz EM, Johnson MS, Robertson DN, Holland PJ, Mitchell R. Endocrinology; 2001 Mar 12; 142(3):1209-17. PubMed ID: 11181537 [Abstract] [Full Text] [Related]
17. Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors. Gourlet P, Vandermeers A, Vandermeers-Piret MC, De Neef P, Waelbroeck M, Robberecht P. Biochim Biophys Acta; 1996 Dec 12; 1314(3):267-73. PubMed ID: 8982281 [Abstract] [Full Text] [Related]
18. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L. Endocrinology; 1995 May 12; 136(5):2088-98. PubMed ID: 7720658 [Abstract] [Full Text] [Related]
19. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate. Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC. Endocrinology; 1996 Jul 12; 137(7):2815-22. PubMed ID: 8770902 [Abstract] [Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC. Jamen F, Puech R, Bockaert J, Brabet P, Bertrand G. Endocrinology; 2002 Apr 12; 143(4):1253-9. PubMed ID: 11897681 [Abstract] [Full Text] [Related] Page: [Next] [New Search]